An octamer motif is required for activation of the inducible nitric oxide synthase promoter in pancreatic β-cells

被引:24
作者
Darville, MI [1 ]
Terryn, S [1 ]
Eizirik, DL [1 ]
机构
[1] Free Univ Brussels, Expt Med Lab, B-1070 Brussels, Belgium
关键词
D O I
10.1210/en.2003-1200
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nitric oxide, generated by the inducible form of nitric oxide synthase ( iNOS), is a potential mediator of cytokine-induced beta-cell dysfunction in type 1 diabetes mellitus. We have previously shown that cytokine-induced iNOS expression is cycloheximide (CHX) sensitive and requires nuclear factor-kappaB (NF-kappaB) activation. In the present study, we show that an octamer motif located 20 bp downstream of the proximal NF-kappaB binding site in the rat iNOS promoter is critical for IL-1beta and interferon-gamma induction of promoter activity in rat primary beta-cells and insulin-producing RINm5F cells. In gel shift assays, the octamer motif bound constitutively the transcription factor Oct1. Neither Oct1 nor NF-kappaB binding activities were blocked by CHX, suggesting that other factor(s) synthesized in response to IL-1beta contribute to iNOS promoter induction. The high mobility group (HMG)-I(Y) protein also bound the proximal iNOS promoter region. HMG-I(Y) binding was decreased in cells treated with CHX and HMG-I( Y) silencing by RNA interference reduced IL-1beta-induced iNOS promoter activity. These results suggest that Oct1, NF-kappaB, and HMG-I( Y) cooperate for transactivation of the iNOS promoter in pancreatic beta-cells.
引用
收藏
页码:1130 / 1136
页数:7
相关论文
共 47 条
[1]  
Amrani Y, 1999, J IMMUNOL, V163, P2128
[2]   Differential in vivo modifications of the HMGI(Y) nonhistone chromatin proteins modulate nucleosome and DNA interactions [J].
Banks, GC ;
Li, Y ;
Reeves, R .
BIOCHEMISTRY, 2000, 39 (28) :8333-8346
[3]   PYRROLIDINE DITHIOCARBAMATE PREVENTS IL-1-INDUCED NITRIC-OXIDE SYNTHASE MESSENGER-RNA, BUT NOT SUPEROXIDE-DISMUTASE MESSENGER-RNA, IN INSULIN-PRODUCING CELLS [J].
BEDOYA, FJ ;
FLODSTROM, M ;
EIZIRIK, DL .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 210 (03) :816-822
[4]   Identification of novel cytokine-induced genes in pancreatic β-cells by high-density oligonucleotide arrays [J].
Cardozo, AK ;
Kruhoffer, M ;
Leeman, R ;
Orntoft, T ;
Eizirik, DL .
DIABETES, 2001, 50 (05) :909-920
[5]   Differential regulation of nitric oxide synthase mRNA expression by lipopolysaccharide and pro-inflammatory cytokines in fetal hepatocytes treated with cycloheximide [J].
Casado, M ;
DiazGuerra, MJM ;
Bosca, L ;
MartinSanz, P .
BIOCHEMICAL JOURNAL, 1997, 327 :819-823
[6]  
COOLIDGE CJ, 1995, BIOTECHNIQUES, V18, P762
[7]   Cytokine induction of Fas gene expression in insulin-producing cells requires the transcription factors NF-κB and C/EBP [J].
Darville, MI ;
Eizirik, DL .
DIABETES, 2001, 50 (08) :1741-1748
[8]   Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells [J].
Darville, MI ;
Eizirik, DL .
DIABETOLOGIA, 1998, 41 (09) :1101-1108
[9]   NF-κB is required for cytokine-induced manganese superoxide dismutase expression in insulin-producing cells [J].
Darville, MI ;
Ho, YS ;
Eizirik, DL .
ENDOCRINOLOGY, 2000, 141 (01) :153-162
[10]   A choice of death - the signal-transduction of immune-mediated beta-cell apoptosis [J].
Eizirik, DL ;
Mandrup-Poulsen, T .
DIABETOLOGIA, 2001, 44 (12) :2115-2133